Thermodynamic study of the influence of NADPH on the binding of methotrexate and its metabolites to a mammalian dihydrofolate reductase

Interaction of methotrexate and some of its metabolites with a mammalian dihydrofolate reductase was studied using two complementary methods, potentiometry and microcalorimetry. The major plasma metabolite of this anticancer agent, 7-hydroxymethotrexate, was found to have a different binding behavio...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 964; no. 1; pp. 53 - 60
Main Authors Gilli, Robert M., Sari, Jean C., Sica, Lucas M., Briand, Claudette M.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 12.01.1988
Elsevier
North-Holland
Subjects
Online AccessGet full text
ISSN0304-4165
0006-3002
1872-8006
DOI10.1016/0304-4165(88)90066-9

Cover

More Information
Summary:Interaction of methotrexate and some of its metabolites with a mammalian dihydrofolate reductase was studied using two complementary methods, potentiometry and microcalorimetry. The major plasma metabolite of this anticancer agent, 7-hydroxymethotrexate, was found to have a different binding behavior from that of polyglutamyl derivatives and of methotrexate itself. Indeed, 7-hydroxymethotrexate binds without a p K shift to dihydrofolate reductase, whereas polyglutamyl derivatives bind to the enzyme with a proton uptake, as the parent drug does. NADPH increases the association constant of the 7-hydroxy metabolite by a factor of 10–20, while for methotrexate and for polyglutamates this increase is about 100-fold. It was demonstrated that the enhancement of the binding by NADPH had an enthalpic origin. Finally, the binding behavior of dihydrofolate reductase seemed to be independent to its enzymatic activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-4165
0006-3002
1872-8006
DOI:10.1016/0304-4165(88)90066-9